# Victor Wang

> Victor Wang is a seed investor at HOF Capital backing Biotechnology and Artificial Intelligence. See 33 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [HOF Capital](https://shizune.co/investors/profile/hof-capital)
- Location: San Francisco, United States
- Total investments: 33
- Last investment: Jun 2026
- Lead investor: 15%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/victorwang1/
- X (Twitter): https://twitter.com/VictorWangJC
- Website: https://x.com/VictorWangJC

Victor Wang is a seed investor at HOF Capital in San Francisco focused on Biotechnology and Artificial Intelligence. Victor Wang is based out of New York, New York and is the Partner of HOF Capital. Victor previously worked at Stanford University as a Researcher. Victor Wang attended the University of California, Berkeley. Victor Wang has received Principal’s Award for Academic Excellence.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $150k–$14M |
| Series A | $10M–$26M |
| Series B | $55M–$143M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 18% |
| Artificial Intelligence | 6 | 18% |
| Health Care | 5 | 15% |
| Machine Learning | 4 | 12% |
| Medical | 3 | 9% |

41 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 12 | 36% |
| Series A | 8 | 24% |
| Series B | 2 | 6% |
| Pre-Seed | 1 | 3% |
| Series C | 1 | 3% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 10 | 30% |
| Singapore | 2 | 6% |
| India | 1 | 3% |
| Brazil | 1 | 3% |
| Taiwan | 1 | 3% |

6 countries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Trace Finance | Trace Finance empowers Payment Facilitators, Crypto & Cross-border companies with best in class FX, Non Resident accounts and cross-border payments. Companies such as Dlocal, Volt.io and Okx are processing their local and cross border payments with us. Our mission is to provide faster and better payments globally for enterprises. 40% ofpayments in stablecoins | $32M | Series A | Jun 17, 2026 |  |
| Extropic AI | Extropic AI is a hardware startup that is building a chip optimized to run large language models, or LLMs. | $14.1M | Seed | Dec 04, 2023 |  |
| Extropic AI | Extropic AI is a hardware startup that is building a chip optimized to run large language models, or LLMs. | $14.1M | Seed | Dec 04, 2023 |  |
| Motion | Motion is an AI time management platform that provides real-time interventions, reminders, and analytics. Motion mark sites as distracting to limit the time on them in the future.The company's tool keeps users from becoming distracted while browsing the web by providing real-time interventions, reminders, and analytics, as well as calendar,tab management, and focus tools. | $13M | Series A | Sep 19, 2022 |  |
| Intellect | Intellect is a modern-day mental health company with a mission to make mental healthcare & wellbeing support accessible for everyone. Today, Intellect is the largest and fastest growing mental health tech company in Asia, and serves over 2 million members and leading organisations globally through our mental health platform. Intellect wasalso selected as one of Google’s Best Apps of 2020. Intellect is backed by leading investors including Insignia Ventures Partners, Y Combinator, and an extensive list of family offices, big tech executives & renowned angel investors. | $19.8M | Series A | Jul 11, 2022 |  |
| BillionToOne | BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to makepre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting in developing countries.BillionToOne was founded in 2016 and is headquartered in Menlo Park, California. | $125M | Series C | Mar 30, 2022 |  |
| Heptabase | Heptabase is the visual note-taking tool for learning complex topics. Heptabase is headquartered in Taipei, Taiwan and was founded in 2021. | $1.7M | Seed | Mar 30, 2022 |  |
| Heptabase | Heptabase is the visual note-taking tool for learning complex topics. Heptabase is headquartered in Taipei, Taiwan and was founded in 2021. | $1.7M | Seed | Mar 30, 2022 |  |
| Dialect | Dialect enables a more engaging dapp experience with timely, targeted messages and notifications. | $4.1M | Seed | Mar 02, 2022 |  |
| Trace Finance | Trace Finance empowers Payment Facilitators, Crypto & Cross-border companies with best in class FX, Non Resident accounts and cross-border payments. Companies such as Dlocal, Volt.io and Okx are processing their local and cross border payments with us. Our mission is to provide faster and better payments globally for enterprises. 40% ofpayments in stablecoins | $4.3M | Seed | Feb 15, 2022 |  |

10 of 33 investments shown.

## Co-investors
- [HOF Capital](https://shizune.co/investors/profile/hof-capital) — VC Fund, 16 deals together
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 8 deals together
- [Civilization Ventures](https://shizune.co/investors/profile/civilization-ventures) — VC Fund, 5 deals together
- [Pioneer Fund](https://shizune.co/investors/profile/pioneer-fund) — VC Fund, 5 deals together
- [Hummingbird Ventures](https://shizune.co/investors/profile/hummingbird-ventures) — VC Fund, 4 deals together
- [Neotribe Ventures](https://shizune.co/investors/profile/neotribe-ventures) — VC Fund, 4 deals together

## About HOF Capital

VC Fund · New York, United States

HOF Capital is a global multistage VC firm with $1 billion in AUM that partners with ambitious entrepreneurs from idea to IPO.

5 contacts available at HOF Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Fady Yacoub | Co-Founder and Partner | https://shizune.co/investors/profile/fady-yacoub |
| Hisham Elhaddad | Co-Founder and Managing Partner | https://shizune.co/investors/profile/hisham-el-haddad |
| Onsi Sawiris | Co-Founder and Managing Partner | https://shizune.co/investors/profile/onsi-sawiris |
| Troy Shen | Senior Associate | https://shizune.co/investors/profile/troy-shen-89bb |
| Victor Wang | Partner | https://shizune.co/investors/profile/victor-wang-3 |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Biotech Angel Investors](https://shizune.co/investors/biotech-angel-investors)
- [Biotech Angel Investors in United States](https://shizune.co/investors/biotech-angel-investors-united-states)
- [Payments Angel Investors in India](https://shizune.co/investors/payments-angel-investors-india)
- [Mobile Apps Angel Investors in India](https://shizune.co/investors/mobile-apps-angel-investors-india)
- [SaaS Angel Investors in South Korea](https://shizune.co/investors/saas-angel-investors-south-korea)
- [All Angel Investors in South Korea](https://shizune.co/investors/angel-investors-south-korea)

## FAQ

### What does Victor Wang invest in?

Victor Wang invests primarily in Biotechnology, Artificial Intelligence and Health Care startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Victor Wang's check size?

Victor Wang typically joins rounds of $150k–$14M at Seed, $10M–$26M at Series A and $55M–$143M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Victor Wang participates in.

### When did Victor Wang last invest?

The most recent investment recorded for Victor Wang closed in Jun 2026. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co